Maurício Rocha e Silva wasn't looking for bradykinin — he was testing a wrong hypothesis about histamine and circulatory shock. The accidental discovery of bradykinin, then of BPF, then of ACE's dual role in blood pressure, handed medicinal chemists a structural lead for captopril that no one had designed from first principles.